The Comparison of the Effects of Two Botulinum Toxin A Injection Methods, Follow the Pain and Fixed-site Fixed-dose, on Improving the Quality of Life and Headaches in Patients with Chronic Migraine: A Preliminary Randomized Clinical Trial

Journal Title: Turkish Journal of Neurology - Year 2020, Vol 26, Issue 4

Abstract

Objective: Migraine headaches are one of the most common and debilitating diseases. Chronic migraine (CM) is a type of migraine that reduces quality of life and causes disability. Botulinum toxin A (BT-A) was approved in 2010 by the Food and Drug Administration for CM as one of the treatment options. In BT-A treatment, follow the pain (FTP), fixed-site fixed-dose (FSFD) methods, and combined injections are prevalent. This clinical trial aimed to compare the effects of two methods of BT-A injections in patients with CM to determine the method with the fewest complications, the strongest therapeutic effects, and the lowest costs in improving quality of life. Materials and Methods: In this preliminary clinical trial, 40 patients with CM were screened, and after examining the inclusion criteria, 18 patients completed the trial. After a baseline examination and experiencing a 28-day baseline period, they were randomly divided into FSFD and FTP groups. In our study, we used the Quality of Life Questionnaire, the Migraine Daily Note, and Headache Impact Test-6. Results: A total of 17 women and 1 man completed the trial. Severity and rate of headaches and quality of life scores had better changes in the following months with similar trends in both groups without a significant difference. Conclusion: The comparison of the scores showed an improvement in most patients, but there was no significant difference between the FSFD and FTP groups. However, the results indicated a greater response to the treatment and a higher rate of drug use in the FSFD group.

Authors and Affiliations

Hossein Salehi, Mohaddaseh Fekri, Alireza Vakilian, Mohsen Rezaeaian, Hassan Ahmadinia

Keywords

Related Articles

The Role of Neurologist in the Assessment and Treatment of Depression

In neurologic illness, depression contributes significantly to impairments in quality of life, independent of the severity of the disease. In the evolution of neurodegenerative disorders, depression may predate neurologi...

Fingolimod Therapy for Pediatric Relapsing-Remitting Multiple Sclerosis: A Real-Life Study

Objective: Clinical studies in childhood multiple sclerosis (MS) are very limited compared with adults. Although first-line injection therapies are well tolerated in this patient group, there are difficulties in the long...

Complete Recovery in Cryptogenic NORSE with Early Immunotherapy: A Case Report

The term new onset refractory status epilepticus (NORSE) is used for patients who do not have a history of seizures and a structural disorder and in whom no etiology can be found. Its treatment is very difficult and its...

Download PDF file
  • EP ID EP691586
  • DOI 10.4274/tnd.2020.56767
  • Views 137
  • Downloads 0

How To Cite

Hossein Salehi, Mohaddaseh Fekri, Alireza Vakilian, Mohsen Rezaeaian, Hassan Ahmadinia (2020). The Comparison of the Effects of Two Botulinum Toxin A Injection Methods, Follow the Pain and Fixed-site Fixed-dose, on Improving the Quality of Life and Headaches in Patients with Chronic Migraine: A Preliminary Randomized Clinical Trial. Turkish Journal of Neurology, 26(4), -. https://europub.co.uk/articles/-A-691586